Skip to main content

Table 4 Correlations between duration and severity of migraine attacks and the laboratory markers of insulin resistance and metabolic syndrome

From: The potential impact of insulin resistance and metabolic syndrome on migraine headache characteristics

 

Attack duration

MEGSEV

HIT

FBS

TGs

HDL

Insulin

HOMA-IR

Attack duration

(r) Coef.

1

0.333

0.366

0.148

0.077

-0.534

0.134

0.299

P-value

.

0.072

0.047*

0.434

0.686

0.002*

0.482

0.108

MEGSEV

(r) Coef.

0.333

1

0.705

0.437

0.302

-0.164

0.486

0.721

P-value

0.072

.

< 0.001*

0.016*

0.104

0.387

0.006*

< 0.001*

HIT

(r) Coef.

0.366

0.705

1

0.325

0.295

-0.026

0.433

0.704

P-value

0.047*

< 0.001*

.

0.08

0.114

0.891

0.017*

< 0.001*

FBS

(r) Coef.

0.148

0.437

0.325

1

0.521

-0.282

0.358

0.390

P-value

0.434

0.016*

0.08

.

0.003*

0.131

0.052

0.033*

TGs

(r) Coef.

0.077

0.302

0.295

0.521

1

-0.213

0.268

0.317

P-value

0.686

0.104

0.114

0.003*

.

0.258

0.152

0.088

HDL

(r) Coef.

-0.534

-0.164

-0.026

-0.282

-0.213

1

0.111

0.071

P-value

0.002*

0.387

0.891

0.131

0.258

.

0.559

0.708

Insulin

(r) Coef.

0.134

0.486

0.433

0.358

0.268

0.111

1

0.813

P-value

0.482

0.006*

0.017*

0.052

0.152

0.559

.

< 0.001*

HOMA-IR

(r) Coef.

0.299

0.721

0.704

0.390

0.317

0.071

0.813

1

P-value

0.108

< 0.001*

< 0.001*

0.033*

0.088

0.708

< 0.001*

.

  1. FBS Fasting blood sugar, HDL High-density lipoprotein, HIT Headache Impact Test-6, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, MIGSEV Migraine Severity Scale, TGs Triglycerides
  2. (r): Spearman coefficient, *P-value ≤ 0.05 is considered significant